Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit focused on accelerating a cure for type 1 diabetes (T1D), announced the release of a...
-
BCC Research, “Contract Manufacturing of Medical Devices: Global Markets” is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030.
-
Trifork Labs company Dawn Health welcomes Cipio Partners to fuel the next phase of growth for AI-driven commercial and clinical companion applications Press releaseCopenhagen — February 10, 2026 —...
-
The global Anti-obesity Drugs market is projected to grow at a CAGR of 24.2% to reach US$195.99 billion by 2036.
-
GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million. Reference is made to the stock exchange announcement published on 27 January 2026...
-
The acquisition expands scalable trial operations across real-world care settings
-
Le venglustat de Sanofi a atteint tous les critères d'évaluation principaux dans une étude de phase 3 sur la maladie de Gaucher de type 3 Dans l’étude de phase 3 LEAP2MONO, le venglustat, administré...
-
Sanofi's investigational drug venglustat improved the neurologic symptoms of type 3 Gaucher disease, for which there are currently no approved therapies.
-
Austin, TX, USA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Spatial Biology Market Size, Trends and Insights By Molecular Technology...
-
Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced...